Lymphvascular space involvement - A prognostic indicator in patients with surgical stage I endometrial adenocarcinoma treated with postoperative radiation

International Journal of Gynecological Cancer

Volumn 6, Issue 2, 1996, Pages 135-139

  Gal, D ^a   Rush, S ^a   Lovecchio, J L ^a   Potters, L ^a   Smilari, T F ^a   Lesser, M ^a   Bosworth, J ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

endometrial cancer; lymphvascular space; pelvic radiation

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029879959     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06020135.x     Document Type: Article

References (42)

1. Creasman WT. Anouncement: FIGO stages-1988 revisions. Gynecol Oncol 1989; 35: 125-7.
2. Delclos L, Wharton JT, Rutledge FN, Fletcher GH and Hamberger AD. Preoperative irradiation in the treatment of adenocarcinoma of the endometrium, stage I: The U.T.M.D. Anderson Hospital experience. Gynecologic Cancer: Diagnosis and Treatment Strategies. Annual Clinical Conference on Cancer. The University of Texas Cancer Center, 1987; 29: 317-26.
3. Salazar OM, Feldstein ML, DePapp EW, et al. Endometrial carcinoma: analysis of failures with special emphasis on the use of initial preoperative external pelvic radiation. Int J Rad Oncol Biol Phys 1977; 2: 1101-7.
4. Grigsby PW, Perez CA, Kuten A, et al. Clinical stage I endometrial cancer: results of adjuvant irradiation and patterns of failure. Int J Rad Oncol Biol Phys 1991; 21: 379-85.
5. Aalders JG, Syde RVD, Poppema S, Szabo BG, Janssens J. Prognostic factors and changing trends in the treatment of stage I endometrial cancer: a clinical and histopathological study of 182 patients. Int J Rad Oncol Biol Phys 1984; 10: 2083-8.
6. Eifel PJ, Ross J, Hendrickson M, Cox RS, Kempson R, Martinez A. Adenocarcinoma of the endometrium, analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons. Cancer 1983; 52: 1026-31.
7. Nori D, Basil SH, Tome M, Lewis JL Jr, Birnbaum S, Fuks, Z. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors, Int J Rad Oncol Biol Phys 1987; 13: 489-97.
8. Reisinger S, Nori D, Lewis JL Jr. Postoperative intravaginal radiation therapy as an adjunct to external irradiation in high-risk endometrial adenocarcinoma: an evaluation of two different dose schedules. Endocurieth Hyperthem Oncol 1991; 7: 35-41.
9. Graham J. The value of preoperative or postoperative treatment by radium for carcinoma of the uterine body. Surg Gynecol Obstet 1971; 137: 855-60.
10. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and stage II carcinoma of the endometrium: a gynecological oncology group study. Gynecol Oncol 1991; 40: 55-65.
11. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-27.
12. Poulsen MG, Roberts SJ. Prognostic variables in endometrial carcinoma. Int J Rad Oncol Biol Phys 1987; 13: 1043-52.
13. Lybeert MLM, van Putten WLJ, Ribot JG, Crommelin MA. Endometrial carcinoma: high-dose brachytherapy in combination with external irradiation: a multivariate analysis of relapses. Radiother Oncol 1989; 16: 245-52.
14. Torrisi JR, Barnes WA, Popescu G, et al. Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinoma. Cancer 1989; 64: 1417.
15. Stryker JA, Podczaski E, Kaminski P, Velkley DE. Adjuvant external beam therapy for pathologic stage I and occult stage II endometria carcinoma. Cancer 1991; 67: 2872-9.
16. Piver MS, Hempling RE. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion for surgical stage I endometrial adenocarcinoma. Cancer 1990; 66: 1133-8.
17. Rush S, Gal D, Potters L, Bosworth J, Lovecchio JL. Is vaginal brachytherapy necessary following external beam radiation for surgical stage 1 endometrial adenocarcinoma. Int J Rad Oncol Biol Phys (in press) 1995.
18. Gal D, Recio FO, Zamurovic D, Tancer ML. Lymph vascular space involvement - A prognostic indicator in patients with endometrial adenocarcinoma. Gynecol Oncol 1991; 42: 142-5.
19. Hanson NB, van Nagell JR Jr, Powell DE, et al. Prognostic significance of lymphvascular space involvement in stage I endometrial cancer. Cancer 1985; 55: 1753-7.
20. Sivridis E, Buckley CH, Fox H. The prognostic significance of lymphatic-vascular space invasion in endometrial adenocarcinoma. Br J Obstet Gynaecol 1987; 94: 991-4.
21. Abler VM, Kjorstad KE. Endometrial adenocarcinoma in Norway: A study of a total population. Cancer 1991; 67: 3093-103.
22. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometroid adenocarcinoma of the uterine corpus. Cancer 1992; 69: 1424-31.
23. Creasman WT, Morrow PC, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer - A gynecologic oncology group study. Cancer 1987; 60: 2035-41.
24. Lee KR, Vacek PM, Belinson JL. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 1994; 54: 10-8.
25. Barber HK, Sommers SC, Rotterdam H, Kwon T. Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstet Gynecol 1978; 52: 343-8.
26. van Nagell JR, Donaldson ES, Wood EG, Parker JC. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer 1978; 41: 228-36.
27. Cherry CP, Gluckman A. Lymphatic embolism and lymph node metastases in cancers of the vulva and of uterine cervix. Cancer 1955; 8: 564-9.
28. Roche WD, Norris HJ. Microinvasive carcinoma of the cervix. The significance of lymphatic invasion and confluent patterns of stromal growth. Cancer 1975; 36: 180-7.
29. Friedell GH, Steiner G, Kistner RW. Prognostic value of blood vessel invasion in cervical cancer, Obstet Gynecol 1967; 29: 855-61.
30. Gauthier P, Gore I, Shingleton HM, Soong SJ, Orr JW Jr, Hatch KD. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 1985; 66: 569-74.
31. Disaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology, St. Louis, CV Mosby Co, 1989: 69.
32. Stephen TJ, Mills PM. Monoclonal antibodies to blood group isoantigens: An alternative marker to factor VIII related antigen for benign and malignant vascular endothelial cells. J Pathol 1985; 147: 139-48.
33. Little D, Said JW, Seigel RJ, Fealy M. Endothelial cell markers in vascular neoplasms. J Pathol 1986; 149: 89-95.
34. Mukai K, Rosai J, Burgdorf WHC. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 1980; 4: 273-6.
35. Burgdorf WHC, Mukai K, Rosai L. Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature. Am J Clin Pathol 1981; 75: 167-71.
36. Sehested M, Hou-Jensen K. Factor VIII-related antigen as an endothelial cell marker in benign and malignant disease. Virchow Arch A Pathol Anat Hist 1981; 391: 217-25.
37. Nagle RB, Witte MH, Martinez AP. Factor VIII associated antigen in human lymphatic endothelium. Lymphology 1987; 20: 20-4.
38. Lee AK, DeLellis RA, Wolfe HJ. Intramammary lymphatic invasion in breast carcinoma. Am J Surg Pathol 1986; 10: 589-94.
39. Lee AK, DeLellis RA, Silverman ML, Heatley GJ, Wolfe HJ. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 1990; 8: 1457-65.
40. Tsuruchi N, Kaku T, Kamura T, et al. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistorchemical staining. Gyn Oncol 1995; 57: 307-12.
41. Gal D, Recio FO, Zamunovic D. The new international federation of gynecology and obstetrics surgical staging and survival rates in early endometrial carcinoma. Cancer 1992; 69: 200-2.
42. Chen SS. Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade II tumor surgically limited to the corpus uteri. Cancer 1989; 63: 1843-5.